15+ Years of Respiratory Pharma Experience

Build Your Respiratory Business With Real-World Respiratory Expertise.

I help pharma entrepreneurs and healthcare businesses identify, develop, launch and scale commercially viable respiratory portfolios.

From Molecule to Market. From Product to Profit.

Explore the RESPIRA™ Framework
Abstract data visualisation of lungs, an inhaler device and a connected institutional healthcare network
15+ Years Experience
Respiratory Portfolio Strategy
Inhalation Devices
Institutional Business
Third-Party Manufacturing
Commercial Strategy

The Business Problem

Entering Respiratory Is Easy. Building a Respiratory Business Is Not.

Product Selection

Which molecules, combinations and dosage forms should you enter?

Device Strategy

DPI, MDI or nebulization—which platform fits the opportunity?

Manufacturing

How do you identify the right third-party manufacturing partner?

Positioning

How do you differentiate from established respiratory brands?

Institutional Sales

How do you build hospital and procurement access?

Commercial Economics

How do you build a portfolio that makes business sense?

Why This Consultant

15+ Years Inside the Respiratory Business

Professional experience across established respiratory brands, inhalation devices, respiratory molecules and commercial execution.

"Experience is valuable when it can be converted into better business decisions."

  1. 15+ Years

  2. Respiratory Pharmaceutical Experience

  3. Established Respiratory Brands

  4. Foracort

  5. Seroflo

  6. Inhalation Devices

  7. Respiratory Molecules & Formulations

  8. Commercial Execution

  9. Business Strategy Consulting

Brand names are referenced solely to describe professional experience. No affiliation with, endorsement by, or ownership of any pharmaceutical company or brand is implied.

Signature Framework

Introducing RESPIRA™

A structured framework for building respiratory businesses.

R

RESEARCH

Explore the RESPIRA™ Framework

Services

Where I Help Respiratory Businesses Win

01

Respiratory Portfolio Strategy

Identify the right products, molecules, combinations and dosage forms for your business model.

02

Inhalation Device Strategy

Evaluate DPI, MDI and nebulization opportunities, device platforms and manufacturing considerations.

03

Third-Party Manufacturing Strategy

Develop a structured framework for evaluating respiratory manufacturers, capabilities, quality systems and commercial economics.

04

Institutional Sales Strategy

Build hospital, procurement, tender, KOL and key-account strategies for respiratory portfolios.

05

Brand & Commercial Strategy

Create differentiated positioning, pricing architecture and go-to-market plans.

06

Respiratory Business Launch

Build the complete roadmap from opportunity assessment to commercial launch.

Flagship Program

Respiratory Business Launch Blueprint™

A practical roadmap for entrepreneurs ready to build a respiratory business.

01

MARKET

Opportunity Assessment

02

PORTFOLIO

Product Selection

03

DEVICE

DPI / MDI / Nebulization Strategy

04

MANUFACTURING

Partner Evaluation

05

COMMERCIAL

Pricing + Positioning + Institutional Strategy

06

LAUNCH

90-Day Execution Roadmap

Strategic Tool

Respiratory Portfolio Scoring Model

Score a respiratory opportunity across eight commercial criteria to see how it holds up before capital is committed.

3/5
3/5
3/5
3/5
3/5
3/5
3/5
3/5

Portfolio Score

24/40

Viable with focused refinement

Portfolio recommendations are strategic screening tools and must be validated against current market data, regulatory requirements, pricing controls, intellectual property and manufacturer capabilities before investment.

Institutional Business

From Pulmonologist to Procurement.

Pulmonologist
HOD / Clinical Team
Pharmacy
Purchase
Finance
Procurement
Supply & Reorder

Clinical adoption and commercial access must be designed together.

Hospital Segmentation
Key Account Strategy
KOL Mapping
Formulary Strategy
Tender Strategy
Institutional Pricing
Sales Team Deployment
Account Growth

Who I Work With

Built for Operators, Not Observers.

Pharma Entrepreneurs

Existing Pharma Companies

PCD Companies

Healthcare Entrepreneurs

Institutional Suppliers

Respiratory Division Builders

Strategic Engagement Model

How an Engagement Actually Runs

Challenge

Entrepreneur wants to enter respiratory with limited capital.

Approach

  1. Market mapping
  2. Portfolio scoring
  3. Device evaluation
  4. Manufacturer screening
  5. Institutional strategy

Output

Prioritized portfolio + manufacturing strategy + commercial roadmap.

Illustrative consulting scenario.

Free Download

Free Respiratory Business Opportunity Map 2026

Before investing in a respiratory portfolio, understand where the opportunities—and the risks—are.

  • 25 Respiratory Opportunity Categories
  • Portfolio Selection Framework
  • DPI vs MDI vs Nebulization
  • Institutional Opportunity Map
  • Third-Party Manufacturing Checklist
  • 10 Common Respiratory Launch Mistakes

Get the Opportunity Map

Consultation

Start With a Respiratory Portfolio Audit

A focused diagnostic session for entrepreneurs and pharma business owners who want to evaluate a respiratory opportunity before committing significant capital.

  • Market opportunity review
  • Current portfolio review
  • Investment-range discussion
  • Product strategy
  • Device strategy
  • Manufacturing considerations
  • Institutional potential
  • Priority action plan